Prostate Cancer
A "rolling average" multiple adaptive planning method to compensate for target volume changes in image-guided radiotherapy of prostate cancer - Abstract
February 6, 2012
Use of androgen deprivation therapy in prostate cancer: Indications and prevalence - Abstract
February 6, 2012
Hematological changes during androgen deprivation therapy - Abstract
February 6, 2012
Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis - Abstract
February 6, 2012
Double-targeted and double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for prostate cancer - Abstract
February 6, 2012
The Epigenetic promise for prostate cancer diagnosis - Abstract
February 6, 2012
Matrine inhibits proliferation and induces apoptosis of the androgen‑independent prostate cancer cell line PC-3 - Abstract
February 3, 2012
Epigenetics in prostate cancer - Abstract
February 3, 2012
Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants - In vivo evidence - Abstract
February 3, 2012
Bone scan index: A quantitative treatment response biomarker for castration-resistant metastatic prostate cancer - Abstract
February 3, 2012
An opposed matched field IMRT technique for prostate cancer patients with bilateral prosthetic hips - Abstract
February 3, 2012